Giuseppe Attanasio
Bellinzona, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Antitumor activity of PAbs generated by immunization with a novel HER3-targeting protein-based vaccine candidate in preclinical models.
Journal: Frontiers in oncology
Published: July 29, 2024
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
Journal: Cancer cell
Published: December 06, 2023
Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer.
Journal: Nature communications
Published: July 20, 2023
Publisher Correction: Contrastive language and vision learning of general fashion concepts.
Journal: Scientific reports
Published: January 23, 2023
VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer.
Journal: Cell communication and signaling : CCS
Published: November 18, 2022
Contrastive language and vision learning of general fashion concepts.
Journal: Scientific reports
Published: May 26, 2022
The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells.
Journal: Nature cancer
Published: May 09, 2022
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer.
Journal: Cancer cell
Published: April 12, 2022
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.
Journal: Science (New York, N.Y.)
Published: October 07, 2021
Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer.
Journal: Nature communications
Published: July 16, 2021
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
Journal: Cancer cell
Published: February 25, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026